PANEL: Building Bridges From Bedside to Bench and Back
Translational research aims to bridge the vast amount of disease knowledge generated at the life science
research bench with an expected benefit at the bedside in the clinical domain. But given the number of
studies performed, papers published, and trials run – compared with the number of new treatment
options reaching patients – it’s apparent that predictive value at the bedside is lagging.
